RING1 and breast cancer: As expected, using the UALCAN dataset (http://ualcan.path.uab.edu), we found that the level of DNA methylation of the RING1 promoter was higher in breast cancer tissues compared to that in normal tissues (P < 0.0001) (Figure 5A).